News

Chevron Corporation (NYSE:CVX) today announced the relocation of the company’s headquarters from San Ramon, California, to Houston, Texas, and senior leadership changes.

Headquarters Relocation

NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.370 per share on the Company’s outstanding Class A and Class B Common Stock payable

Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2024 and raised its full-year 2024 guidance⁽¹⁾ for both Revenues and Adjusted⁽²⁾ diluted EPS.

The second-quarter 2024

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX^® (fidanacogene elaparvovec), a gene therapy for the treatment

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gene therapy for the

Exxon Mobil Corporation (NYSE: XOM) will release its second quarter 2024 financial results on Friday, August 2, 2024. The company will issue a press release via Business Wire that will be available

American Express Company (NYSE: AXP) today reported second-quarter net income of $3.0 billion, or $4.15 per share, compared with net income of $2.2 billion, or $2.89 per share, a year ago

Calvert Impact today announced the launch of Access by Calvert Impact, a national public-private partnership to support small businesses, with the closing of an $140 million warehouse credit

Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation

Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and President, Pfizer Research &amp

The Board of Directors of American Express Company (NYSE: AXP) has declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $9,072.22 per

Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, August 2, 2024, at 11:00 a.m. ET (8:00 a.m. PT).

Pfizer Inc. (NYSE: PFE) today announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Mr. Taraporevala, age 57, was also appointed to and will join the Audit

NIKE, Inc. (NYSE:NKE) today reported financial results for its fiscal 2024 fourth quarter and full year ended May 31, 2024.

• 
  Full year revenues were $51.4 billion compared to $51.2 billion in

Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 third-quarter 2024 dividend on the company’s common stock, payable September 3, 2024, to holders of the Common

ExxonMobil (NYSE: XOM) has signed a non-binding memorandum of understanding (MOU) with SK On, a global leading electric vehicle (EV) battery developer, that opens the door to secure a multiyear

ExxonMobil (NYSE: XOM) and Air Liquide today announced an agreement to support the production of low-carbon hydrogen and low-carbon ammonia at ExxonMobil’s Baytown, Texas facility. The agreement

American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, July 19, 2024, to discuss second-quarter 2024 financial results

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday, July 30, 2024. The

Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed or

Pfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin gene therapy

Walmart Inc. (NYSE: WMT) announced today that company leadership will participate in upcoming investor events. Links to those with live webcasts can be found on Walmart’s investor relations website

NIKE, Inc. (NYSE: NKE) plans to release its fourth quarter fiscal 2024 financial results on Thursday, June 27, 2024, at approximately 1:15 p.m. PT, following the close of regular stock market

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 45^th Annual